AU2018313253B2 - Truncated guinea pig L-asparaginase variants and methods of use - Google Patents
Truncated guinea pig L-asparaginase variants and methods of use Download PDFInfo
- Publication number
- AU2018313253B2 AU2018313253B2 AU2018313253A AU2018313253A AU2018313253B2 AU 2018313253 B2 AU2018313253 B2 AU 2018313253B2 AU 2018313253 A AU2018313253 A AU 2018313253A AU 2018313253 A AU2018313253 A AU 2018313253A AU 2018313253 B2 AU2018313253 B2 AU 2018313253B2
- Authority
- AU
- Australia
- Prior art keywords
- seq
- gpa
- variant
- asparaginase
- truncated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
- C12N9/82—Asparaginase (3.5.1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01001—Asparaginase (3.5.1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Veterinary Medicine (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762544396P | 2017-08-11 | 2017-08-11 | |
| US201762544411P | 2017-08-11 | 2017-08-11 | |
| US62/544,396 | 2017-08-11 | ||
| US62/544,411 | 2017-08-11 | ||
| PCT/US2018/046196 WO2019032952A1 (en) | 2017-08-11 | 2018-08-10 | TRUNCATED VARIANTS OF INDIA PIG ASPARAGINASE AND METHODS OF USE |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2018313253A1 AU2018313253A1 (en) | 2020-02-27 |
| AU2018313253B2 true AU2018313253B2 (en) | 2024-09-26 |
Family
ID=63405429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2018313253A Active AU2018313253B2 (en) | 2017-08-11 | 2018-08-10 | Truncated guinea pig L-asparaginase variants and methods of use |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US11578315B2 (enExample) |
| EP (1) | EP3664832B1 (enExample) |
| JP (1) | JP7744621B2 (enExample) |
| CN (1) | CN111050784B (enExample) |
| AU (1) | AU2018313253B2 (enExample) |
| CA (1) | CA3106549A1 (enExample) |
| ES (1) | ES2965372T3 (enExample) |
| WO (1) | WO2019032952A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114292853A (zh) * | 2021-11-29 | 2022-04-08 | 国药集团动物保健股份有限公司 | Sumo促溶表达标签及其应用、sumo促溶表达蛋白、重组菌株及蛋白的制备方法 |
| CN114369173B (zh) * | 2022-03-22 | 2022-07-08 | 中国农业科学院北京畜牧兽医研究所 | 一种利用融合蛋白标签促进人颗粒溶素及动物NK lysin在毕赤酵母中表达的方法 |
| CN116459344B (zh) * | 2023-04-28 | 2025-03-18 | 上海市生物医药技术研究院 | 一种MNSFβ/RC3H1 PPI干扰多肽的抗炎治疗应用 |
| WO2025026424A1 (en) * | 2023-08-02 | 2025-02-06 | The Hong Kong Polytechnic University | Bioengineered asparaginase fusion proteins |
| WO2025210068A1 (en) | 2024-04-03 | 2025-10-09 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts | Activity-improved variants of human asparaginase 1 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0811687A2 (en) * | 1996-06-07 | 1997-12-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Polypeptides having l-asparaginase activity |
| WO2012170640A1 (en) * | 2011-06-07 | 2012-12-13 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for trail-drug combination therapy |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| US6267964B1 (en) | 1989-08-01 | 2001-07-31 | Affibody Technology Sweden Ab | Stabilized protein or peptide conjugates able to bond albumin having extended biological half-lives |
| SE9002213D0 (sv) | 1990-06-21 | 1990-06-21 | Hightech Receptor Ab | Albumin binding proteins |
| US5766897A (en) | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| US6565841B1 (en) | 1991-03-15 | 2003-05-20 | Amgen, Inc. | Pulmonary administration of granulocyte colony stimulating factor |
| US5932462A (en) | 1995-01-10 | 1999-08-03 | Shearwater Polymers, Inc. | Multiarmed, monofunctional, polymer for coupling to molecules and surfaces |
| JP3721210B2 (ja) * | 1995-02-08 | 2005-11-30 | 株式会社林原生物化学研究所 | 哺乳類のl−アスパラギナーゼをコードするdna |
| JP3819540B2 (ja) * | 1996-06-07 | 2006-09-13 | 株式会社林原生物化学研究所 | L−アスパラギナーゼ活性を有する哺乳類由来のポリペプチド |
| JP2003518075A (ja) | 1999-12-24 | 2003-06-03 | ジェネンテック・インコーポレーテッド | 生理活性化合物の消失半減期延長のための方法及び組成物 |
| US20040001827A1 (en) | 2002-06-28 | 2004-01-01 | Dennis Mark S. | Serum albumin binding peptides for tumor targeting |
| US20050287153A1 (en) | 2002-06-28 | 2005-12-29 | Genentech, Inc. | Serum albumin binding peptides for tumor targeting |
| US20020065397A1 (en) | 2000-10-12 | 2002-05-30 | Joseph Roberts | Protecting therapeutic compositions from host-mediated inactivation |
| WO2004112717A2 (en) * | 2003-06-17 | 2004-12-29 | Harrison Roger G | Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| US7655413B2 (en) | 2003-06-26 | 2010-02-02 | Lifesensors, Inc. | Methods and compositions for enhanced protein expression and purification |
| DE05733048T1 (de) | 2004-04-06 | 2007-05-10 | Affibody Ab | Serumalbuminbindende peptidkonjugate zur arzneimittelherstellung |
| WO2007103290A2 (en) | 2006-03-03 | 2007-09-13 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Materials and methods directed to asparagine synthetase and asparaginase therapies |
| EP1894940A1 (en) * | 2006-08-28 | 2008-03-05 | Apogenix GmbH | TNF superfamily fusion proteins |
| US20090131317A1 (en) | 2007-06-22 | 2009-05-21 | Affymax, Inc. | Compounds and peptides that bind the trail receptor |
| TW201431558A (zh) * | 2009-08-15 | 2014-08-16 | 建南德克公司 | 用於治療先前治療過之乳癌之抗-血管新生療法 |
| US20120148559A1 (en) * | 2010-12-01 | 2012-06-14 | Board Of Regents The University Of Texas System | Compositions and method for deimmunization of proteins |
| US20150044208A1 (en) | 2011-09-23 | 2015-02-12 | Technophage, Investigaçäo E Desenvolvimento Em Biotecnologia, Sa | Modified Albumin-Binding Domains and Uses Thereof to Improve Pharmacokinetics |
| CN103184209B (zh) * | 2011-12-27 | 2015-09-16 | 拜奥生物科技(上海)有限公司 | 人精氨酸酶和聚乙二醇化人精氨酸酶及其应用 |
| AU2013266215B2 (en) | 2012-05-25 | 2017-12-07 | Janssen Biotech, Inc. | Non-natural consensus albumin binding domains |
| NO2776305T3 (enExample) | 2014-04-23 | 2018-01-27 |
-
2018
- 2018-08-10 EP EP18760167.9A patent/EP3664832B1/en active Active
- 2018-08-10 JP JP2020507589A patent/JP7744621B2/ja active Active
- 2018-08-10 US US16/637,070 patent/US11578315B2/en active Active
- 2018-08-10 AU AU2018313253A patent/AU2018313253B2/en active Active
- 2018-08-10 CN CN201880051871.2A patent/CN111050784B/zh active Active
- 2018-08-10 ES ES18760167T patent/ES2965372T3/es active Active
- 2018-08-10 CA CA3106549A patent/CA3106549A1/en active Pending
- 2018-08-10 WO PCT/US2018/046196 patent/WO2019032952A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0811687A2 (en) * | 1996-06-07 | 1997-12-10 | Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo | Polypeptides having l-asparaginase activity |
| WO2012170640A1 (en) * | 2011-06-07 | 2012-12-13 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for trail-drug combination therapy |
Also Published As
| Publication number | Publication date |
|---|---|
| EP3664832C0 (en) | 2023-10-18 |
| JP2020530300A (ja) | 2020-10-22 |
| US20200239867A1 (en) | 2020-07-30 |
| EP3664832B1 (en) | 2023-10-18 |
| CN111050784B (zh) | 2024-03-19 |
| ES2965372T3 (es) | 2024-04-15 |
| AU2018313253A1 (en) | 2020-02-27 |
| WO2019032952A1 (en) | 2019-02-14 |
| EP3664832A1 (en) | 2020-06-17 |
| US11578315B2 (en) | 2023-02-14 |
| CN111050784A (zh) | 2020-04-21 |
| CA3106549A1 (en) | 2019-02-14 |
| JP7744621B2 (ja) | 2025-09-26 |
| WO2019032952A8 (en) | 2019-07-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018313253B2 (en) | Truncated guinea pig L-asparaginase variants and methods of use | |
| KR102139844B1 (ko) | 암 표적화 치료용 알부민-결합 아르기닌 데이미나제를 포함하는 약제학적 조성물 | |
| TWI418787B (zh) | 原核生物苯丙胺酸解氨酶組合物及使用該組合物治療癌症之方法 | |
| US10526638B2 (en) | Engineered enzymes with methionine-gamma-lyase enzymes and pharmacological preparations thereof | |
| KR102076364B1 (ko) | 사람 아르기나제 및 페길화된 사람 아르기나제 및 그의 용도 | |
| JP7091248B2 (ja) | 低減されたl-グルタミナーゼ活性および増強された安定性を有するl-アスパラギナーゼ変異体および融合タンパク質 | |
| JP2018527926A (ja) | 改変された炭疽毒素保護抗原 | |
| WO2007058381A1 (ja) | 基質特異性を変換した新規高機能酵素 | |
| US20250075196A1 (en) | Adenosine deaminase 1 compositions and methods for using same | |
| HK40001775A (en) | L-asparaginase variants and fusion proteins with reduced l-glutaminase activity and enhanced stability | |
| OA17472A (en) | Pharmaceutical composition comprising albumin-binding arginine deiminase for cancer targeting treatment. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| HB | Alteration of name in register |
Owner name: THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Free format text: FORMER NAME(S): THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS Owner name: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS Free format text: FORMER NAME(S): THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS |
|
| FGA | Letters patent sealed or granted (standard patent) |